The treatment of aggressive prolactinomas with everolimus
ConclusionEverolimus is an active agent in the treatment of prolactinomas that warrants further investigation.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Brain | Cancer & Oncology | Databases & Libraries | Endocrinology | Neurology | Pituitary Tumor | Temodar